Prevalence and Factors Associated with Subclinical Hypothyroidism in Major Depressive Disorder Patients with Dyslipidemia.

Authors:
Zhan L; Yin H; Gao Y; Li Y; Ma J.

Journal:
Neuropsychiatr Dis Treat

Publication Year: 2023

DOI:
10.2147/NDT.S435138

PMCID:
PMC10618397

PMID:
37920820

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Neuropsychiatr Dis Treat

Abbreviation: Neuropsychiatr Dis Treat

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Clinical Neurology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
4-Hydroxysesamin, a Modified Natural Compound, Attenuates Neuronal Apoptosis After Ischemic Stroke …
Wang L; Qu Z; Sun Q and 3 more (2024) - Transparency Score: 3/6
A Cross-Sectional Survey on Psychological Health and Influencing Factors Among 2628 Asymptomatic an…
Zhao M; Liu FX; Wang XL and 2 more (2024) - Transparency Score: 3/6
A Thematic Analysis Investigating the Inaugural Psychosis REACH Family Ambassador Peer Training Pro…
Vaswani-Bye A; McCain C; Blank JM and 2 more (2024) - Transparency Score: 3/6
Biological Markers in Newly Diagnosed Generalized Anxiety Disorder Patients: 8-OHdG, S100B and Oxid…
Oktay M; Asoğlu M; Taskin S and 1 more (2024) - Transparency Score: 3/6
Characteristics of Oral-Gut Microbiota in Model Rats with CUMS-Induced Depression.
Li Y; Liu P. (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
2/6
33.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosure The authors declare that they have no competing interests."

Funding Disclosure
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025